Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s Device Payments Will Continue To Decline, Government Official Says

This article was originally published in The Gray Sheet

Executive Summary

Pressures on reimbursement in Japan will not ease anytime soon and more payment cuts for medical devices are expected in 2008, according to a top Japanese health official

You may also be interested in...



Manufacturers Negotiate With Japan For Higher User Fees To Speed Review

By April 1 of next year the number of medical device reviewers in Japan could increase dramatically via a substantial raise in industry-paid user fees

Manufacturers Negotiate With Japan For Higher User Fees To Speed Review

By April 1 of next year the number of medical device reviewers in Japan could increase dramatically via a substantial raise in industry-paid user fees

Japan price cuts loom less

AdvaMed is "cautiously optimistic" that upcoming biannual cuts in reimbursement for medical devices in Japan will be in aggregate less severe than in the past, the trade group's CEO Steve Ubl said. Japan's MHLW has already released its proposal to manufacturers, who have the opportunity to raise objections. The final reimbursement levels, which take effect April 1, are expected to be released shortly. The device industry continues to lobby against Japan's use of foreign average pricing and other measures to reduce device payments (1"The Gray Sheet" Oct. 8, 2007, p. 3)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel